Literature DB >> 35821184

Different treatment strategies in primary hyperparathyroidism during pregnancy.

A Eremkina1, E Bibik2, S Mirnaya3, J Krupinova1, A Gorbacheva1, E Dobreva1, N Mokrysheva1.   

Abstract

PURPOSE: Primary hyperparathyroidism (PHPT) in pregnancy is rare enough and can be unrecognized because of nonspecific symptoms in most cases, but life-threatening complications for mother, fetus and neonate also occurs. PHPT requires frequent monitoring of the mother and fetus by a multidisciplinary team. Diagnostics and treatment approaches are limited and require individual risk-benefit assessment.
METHODS: In this paper we describe 3 cases of PHPT in pregnant women with different managing approaches (surveillance, drug therapy and surgical treatment) and successful outcomes. Additionally, the most actual literature data on this problem is reviewed.
RESULTS: The management of PHPT in pregnancy should be based on the clinical features, severity of hypercalcemia, gestational age and patient's preference. In the first case a conservative approach with low-calcium diet and oral hydration resulted in mother's reduced serum calcium level before delivery. The second patient had severe hypercalcemia and absolute indications for surgery that was successfully performed at 25 week of gestation. The third woman received cinacalcet because of severe hypercalcemia and potential perioperative risks in the third trimester with an improvement in well-being.
CONCLUSION: Nowadays parathyroidectomy is the best choice for patients with symptomatic PHPT and severe hypercalcemia. This intervention should be carried out preferably in the second trimester to avoid maternal and fetal complications. Mild forms of the disease can require just a conservative management. The drug treatment of PHPT during pregnancy is still controversial.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Cinacalcet; Hypercalcemia; Parathyroid adenoma; Pregnancy; Primary hyperparathyroidism

Mesh:

Substances:

Year:  2022        PMID: 35821184     DOI: 10.1007/s12020-022-03127-3

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.925


  19 in total

1.  Association of parathyroid adenoma and pregnancy with preeclampsia.

Authors:  Hella Hultin; Per Hellman; Ewa Lundgren; Matts Olovsson; Anders Ekbom; Jonas Rastad; Scott M Montgomery
Journal:  J Clin Endocrinol Metab       Date:  2009-06-16       Impact factor: 5.958

2.  Hyperparathyroidism in pregnancy: options for localization and surgical therapy.

Authors:  Todd P W McMullen; Diana L Learoyd; David C Williams; Mark S Sywak; Stan B Sidhu; Leigh W Delbridge
Journal:  World J Surg       Date:  2010-08       Impact factor: 3.352

3.  Pregnancy outcomes in women with primary hyperparathyroidism.

Authors:  Dania Hirsch; Vered Kopel; Varda Nadler; Sigal Levy; Yoel Toledano; Gloria Tsvetov
Journal:  J Clin Endocrinol Metab       Date:  2015-03-09       Impact factor: 5.958

4.  Course and outcome of pregnancy in a patient with mild, asymptomatic, primary hyperparathyroidism diagnosed before conception.

Authors:  S R Tollin
Journal:  Am J Med Sci       Date:  2000-08       Impact factor: 2.378

5.  Primary hyperparathyroidism in pregnancy.

Authors:  A Kristoffersson; S Dahlgren; F Lithner; J Järhult
Journal:  Surgery       Date:  1985-03       Impact factor: 3.982

6.  Pregnancy outcomes in women with primary hyperparathyroidism.

Authors:  Ali Abood; Peter Vestergaard
Journal:  Eur J Endocrinol       Date:  2014-04-17       Impact factor: 6.664

7.  Primary hyperparathyroidism in young people. When should we perform genetic testing for multiple endocrine neoplasia 1 (MEN-1)?

Authors:  T Lassen; L Friis-Hansen; A K Rasmussen; U Knigge; U Feldt-Rasmussen
Journal:  J Clin Endocrinol Metab       Date:  2014-04-14       Impact factor: 5.958

Review 8.  Primary hyperparathyroidism: review and recommendations on evaluation, diagnosis, and management. A Canadian and international consensus.

Authors:  A A Khan; D A Hanley; R Rizzoli; J Bollerslev; J E M Young; L Rejnmark; R Thakker; P D'Amour; T Paul; S Van Uum; M Zakaria Shrayyef; D Goltzman; S Kaiser; N E Cusano; R Bouillon; L Mosekilde; A W Kung; S D Rao; S K Bhadada; B L Clarke; J Liu; Q Duh; E Michael Lewiecki; F Bandeira; R Eastell; C Marcocci; S J Silverberg; R Udelsman; K Shawn Davison; J T Potts; M L Brandi; J P Bilezikian
Journal:  Osteoporos Int       Date:  2016-09-09       Impact factor: 4.507

9.  A Case of Pregnancy Complicated by Primary Hyperparathyroidism Due to a Parathyroid Adenoma.

Authors:  Natalia G Mokrysheva; Anna K Eremkina; Svetlana S Mirnaya; Lyudmila Y Rozhinskaya; Nikolay S Kuznetsov; Rosa M Yesayan; Natalia E Kan; Ekaterina N Dudinskaya
Journal:  Am J Case Rep       Date:  2019-01-14

10.  Seventeen Cases of Primary Hyperparathyroidism in Pregnancy: A Call for Management Guidelines.

Authors:  Aimee Natasha DiMarco; Karim Meeran; Ioannis Christakis; Vinpreet Sodhi; Catherine Nelson-Piercy; Neil Samuel Tolley; Francesco Fausto Palazzo
Journal:  J Endocr Soc       Date:  2019-02-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.